Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs6025

Current Build 156

Released September 21, 2022

Organism
Homo sapiens
Position
chr1:169549811 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
C>A / C>T
Variation Type
SNV Single Nucleotide Variation
Frequency
T=0.016744 (4432/264690, TOPMED)
T=0.022585 (3828/169494, ALFA)
T=0.017619 (2471/140250, GnomAD) (+ 5 more)
T=0.00618 (486/78700, PAGE_STUDY)
T=0.0059 (38/6404, 1000G_30x)
C=0.0000 (0/2930, KOREAN)
A=0.0000 (0/2930, KOREAN)
T=0.0088 (10/1134, HapMap)
Clinical Significance
Reported in ClinVar
Gene : Consequence
F5 : Missense Variant
Publications
184 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20231103111315
Population Group Sample Size Ref Allele Alt Allele Ref HMOZ Alt HMOZ HTRZ HWEP
Total Global 185916 C=0.977592 T=0.022408 0.9557 0.000516 0.043783 0
European Sub 145872 C=0.974471 T=0.025529 0.949572 0.000631 0.049797 0
African Sub 15632 C=0.99507 T=0.00493 0.990148 0.0 0.009852 0
African Others Sub 550 C=0.998 T=0.002 0.996364 0.0 0.003636 0
African American Sub 15082 C=0.99496 T=0.00504 0.989922 0.0 0.010078 0
Asian Sub 3714 C=1.0000 T=0.0000 1.0 0.0 0.0 N/A
East Asian Sub 3016 C=1.0000 T=0.0000 1.0 0.0 0.0 N/A
Other Asian Sub 698 C=1.000 T=0.000 1.0 0.0 0.0 N/A
Latin American 1 Sub 1254 C=0.9872 T=0.0128 0.974482 0.0 0.025518 0
Latin American 2 Sub 5380 C=0.9879 T=0.0121 0.975836 0.0 0.024164 0
South Asian Sub 360 C=0.992 T=0.008 0.983333 0.0 0.016667 0
Other Sub 13704 C=0.97950 T=0.02050 0.959282 0.000292 0.040426 0


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
TopMed Global Study-wide 264690 C=0.983256 T=0.016744
Allele Frequency Aggregator Total Global 169494 C=0.977415 T=0.022585
Allele Frequency Aggregator European Sub 135734 C=0.974642 T=0.025358
Allele Frequency Aggregator Other Sub 12252 C=0.97984 T=0.02016
Allele Frequency Aggregator African Sub 10800 C=0.99491 T=0.00509
Allele Frequency Aggregator Latin American 2 Sub 5380 C=0.9879 T=0.0121
Allele Frequency Aggregator Asian Sub 3714 C=1.0000 T=0.0000
Allele Frequency Aggregator Latin American 1 Sub 1254 C=0.9872 T=0.0128
Allele Frequency Aggregator South Asian Sub 360 C=0.992 T=0.008
gnomAD - Genomes Global Study-wide 140250 C=0.982381 T=0.017619
gnomAD - Genomes European Sub 75950 C=0.97300 T=0.02700
gnomAD - Genomes African Sub 42032 C=0.99534 T=0.00466
gnomAD - Genomes American Sub 13662 C=0.99041 T=0.00959
gnomAD - Genomes Ashkenazi Jewish Sub 3324 C=0.9789 T=0.0211
gnomAD - Genomes East Asian Sub 3130 C=1.0000 T=0.0000
gnomAD - Genomes Other Sub 2152 C=0.9893 T=0.0107
The PAGE Study Global Study-wide 78700 C=0.99382 T=0.00618
The PAGE Study AfricanAmerican Sub 32516 C=0.99459 T=0.00541
The PAGE Study Mexican Sub 10810 C=0.99084 T=0.00916
The PAGE Study Asian Sub 8318 C=0.9995 T=0.0005
The PAGE Study PuertoRican Sub 7916 C=0.9972 T=0.0028
The PAGE Study NativeHawaiian Sub 4534 C=0.9932 T=0.0068
The PAGE Study Cuban Sub 4230 C=0.9868 T=0.0132
The PAGE Study Dominican Sub 3828 C=0.9948 T=0.0052
The PAGE Study CentralAmerican Sub 2450 C=0.9906 T=0.0094
The PAGE Study SouthAmerican Sub 1982 C=0.9884 T=0.0116
The PAGE Study NativeAmerican Sub 1260 C=0.9825 T=0.0175
The PAGE Study SouthAsian Sub 856 C=0.988 T=0.012
1000Genomes_30x Global Study-wide 6404 C=0.9941 T=0.0059
1000Genomes_30x African Sub 1786 C=1.0000 T=0.0000
1000Genomes_30x Europe Sub 1266 C=0.9889 T=0.0111
1000Genomes_30x South Asian Sub 1202 C=0.9884 T=0.0116
1000Genomes_30x East Asian Sub 1170 C=1.0000 T=0.0000
1000Genomes_30x American Sub 980 C=0.990 T=0.010
KOREAN population from KRGDB KOREAN Study-wide 2930 C=0.0000 A=0.0000
HapMap Global Study-wide 1134 C=0.9912 T=0.0088
HapMap American Sub 670 C=0.987 T=0.013
HapMap Europe Sub 176 C=0.994 T=0.006
HapMap Asian Sub 168 C=1.000 T=0.000
HapMap African Sub 120 C=1.000 T=0.000
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 1 NC_000001.11:g.169549811C>A
GRCh38.p14 chr 1 NC_000001.11:g.169549811C>T
GRCh37.p13 chr 1 NC_000001.10:g.169519049T>C
GRCh37.p13 chr 1 NC_000001.10:g.169519049T>A
F5 RefSeqGene (LRG_553) NG_011806.1:g.41721G>T
F5 RefSeqGene (LRG_553) NG_011806.1:g.41721G>A
Gene: F5, coagulation factor V (minus strand)
Molecule type Change Amino acid[Codon] SO Term
F5 transcript NM_000130.5:c.1601G>T R [CGA] > L [CTA] Coding Sequence Variant
coagulation factor V preproprotein NP_000121.2:p.Arg534Leu R (Arg) > L (Leu) Missense Variant
F5 transcript NM_000130.5:c.1601G>A R [CGA] > Q [CAA] Coding Sequence Variant
coagulation factor V preproprotein NP_000121.2:p.Arg534Gln R (Arg) > Q (Gln) Missense Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: C= (allele ID: 227743 )
ClinVar Accession Disease Names Clinical Significance
RCV000514863.17 not provided Conflicting-Interpretations-Of-Pathogenicity
RCV001081351.5 Factor V deficiency Benign
Allele: T (allele ID: 15681 )
ClinVar Accession Disease Names Clinical Significance
RCV000000675.6 Ischemic stroke Risk-Factor
RCV000000676.5 Budd-Chiari syndrome, susceptibility to Risk-Factor
RCV000023935.5 Pregnancy loss, recurrent, susceptibility to, 1 Risk-Factor
RCV000205002.18 Factor V deficiency Pathogenic,Risk-Factor
RCV000454249.9 Thrombophilia due to activated protein C resistance Pathogenic
RCV000616414.4 not specified Pathogenic
RCV001095681.2 Factor V deficiency,Thrombophilia due to activated protein C resistance Pathogenic
RCV001806997.2 Susceptibility to severe coronavirus disease (COVID-19) due to an impaired coagulation process Uncertain-Significance
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement C= A T
GRCh38.p14 chr 1 NC_000001.11:g.169549811= NC_000001.11:g.169549811C>A NC_000001.11:g.169549811C>T
GRCh37.p13 chr 1 NC_000001.10:g.169519049T>C NC_000001.10:g.169519049T>A NC_000001.10:g.169519049=
F5 RefSeqGene (LRG_553) NG_011806.1:g.41721= NG_011806.1:g.41721G>T NG_011806.1:g.41721G>A
F5 transcript NM_000130.5:c.1601= NM_000130.5:c.1601G>T NM_000130.5:c.1601G>A
F5 transcript NM_000130.4:c.1601= NM_000130.4:c.1601G>T NM_000130.4:c.1601G>A
coagulation factor V preproprotein NP_000121.2:p.Arg534= NP_000121.2:p.Arg534Leu NP_000121.2:p.Arg534Gln
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

150 SubSNP, 7 Frequency, 10 ClinVar submissions
No Submitter Submission ID Date (Build)
1 WIAF-CSNP ss7639 Sep 19, 2000 (52)
2 TSC-CSHL ss3388517 Sep 28, 2001 (100)
3 WI_SSAHASNP ss6408627 Feb 20, 2003 (111)
4 PGA-UW-FHCRC ss12674255 Dec 05, 2003 (119)
5 WUGSC_SSAHASNP ss14458528 Dec 05, 2003 (119)
6 SC_SNP ss15384064 Feb 27, 2004 (120)
7 CSHL-HAPMAP ss17374119 Feb 27, 2004 (120)
8 SSAHASNP ss20553759 Apr 05, 2004 (121)
9 PERLEGEN ss68784225 May 17, 2007 (127)
10 ILLUMINA ss74903136 Dec 06, 2007 (129)
11 HGSV ss77657762 Dec 06, 2007 (129)
12 HGSV ss80768688 Dec 15, 2007 (130)
13 HGSV ss84523906 Dec 15, 2007 (130)
14 BCMHGSC_JDW ss87863257 Mar 23, 2008 (129)
15 HUMANGENOME_JCVI ss97982940 Feb 05, 2009 (130)
16 SNP500CANCER ss105435572 Feb 05, 2009 (130)
17 BGI ss106609833 Feb 05, 2009 (130)
18 1000GENOMES ss108686946 Jan 23, 2009 (130)
19 1000GENOMES ss111314932 Jan 25, 2009 (130)
20 ILLUMINA-UK ss119081774 Feb 15, 2009 (130)
21 ENSEMBL ss131709017 Dec 01, 2009 (131)
22 ENSEMBL ss138101430 Dec 01, 2009 (131)
23 GMI ss155905226 Dec 01, 2009 (131)
24 SEATTLESEQ ss159699610 Dec 01, 2009 (131)
25 ILLUMINA ss160758444 Dec 01, 2009 (131)
26 COMPLETE_GENOMICS ss164374094 Jul 04, 2010 (132)
27 COMPLETE_GENOMICS ss165406825 Jul 04, 2010 (132)
28 COMPLETE_GENOMICS ss167258185 Jul 04, 2010 (132)
29 OMICIA ss169613390 Jan 25, 2013 (137)
30 ILLUMINA ss173964819 Jul 04, 2010 (132)
31 PAGE_STUDY ss181341854 Jul 04, 2010 (132)
32 BUSHMAN ss199221578 Jul 04, 2010 (132)
33 BCM-HGSC-SUB ss205068124 Jul 04, 2010 (132)
34 1000GENOMES ss218708130 Jul 14, 2010 (132)
35 1000GENOMES ss230774116 Jul 14, 2010 (132)
36 1000GENOMES ss238413632 Jul 15, 2010 (132)
37 ILLUMINA ss244304161 Jul 04, 2010 (132)
38 OMIM-CURATED-RECORDS ss252841304 Aug 10, 2010 (132)
39 BL ss253592200 May 09, 2011 (134)
40 GMI ss276094736 May 04, 2012 (137)
41 GMI ss284172225 Apr 25, 2013 (138)
42 PJP ss290659975 May 09, 2011 (134)
43 NHLBI-ESP ss342010061 May 09, 2011 (134)
44 ILLUMINA ss482137838 May 04, 2012 (137)
45 ILLUMINA ss482205031 Sep 08, 2015 (146)
46 ILLUMINA ss483027973 May 04, 2012 (137)
47 1000GENOMES ss489776588 May 04, 2012 (137)
48 EXOME_CHIP ss491305652 May 04, 2012 (137)
49 CLINSEQ_SNP ss491609172 May 04, 2012 (137)
50 ILLUMINA ss535048159 Sep 08, 2015 (146)
51 TISHKOFF ss554827710 Apr 25, 2013 (138)
52 SSMP ss648487054 Apr 25, 2013 (138)
53 ILLUMINA ss780124263 Sep 08, 2015 (146)
54 ILLUMINA ss781957563 Sep 08, 2015 (146)
55 ILLUMINA ss835607295 Sep 08, 2015 (146)
56 JMKIDD_LAB ss974438194 Aug 21, 2014 (142)
57 EVA-GONL ss975794409 Aug 21, 2014 (142)
58 JMKIDD_LAB ss1067428640 Aug 21, 2014 (142)
59 JMKIDD_LAB ss1068350648 Aug 21, 2014 (142)
60 1000GENOMES ss1293348588 Aug 21, 2014 (142)
61 HAMMER_LAB ss1397263621 Sep 08, 2015 (146)
62 DDI ss1426011906 Apr 01, 2015 (144)
63 EVA_GENOME_DK ss1574463850 Apr 01, 2015 (144)
64 EVA_FINRISK ss1584012785 Apr 01, 2015 (144)
65 EVA_DECODE ss1585179911 Apr 01, 2015 (144)
66 EVA_UK10K_ALSPAC ss1601439505 Apr 01, 2015 (144)
67 EVA_UK10K_TWINSUK ss1644433538 Apr 01, 2015 (144)
68 EVA_EXAC ss1685903694 Apr 01, 2015 (144)
69 EVA_MGP ss1710931971 Apr 01, 2015 (144)
70 EVA_SVP ss1712380140 Apr 01, 2015 (144)
71 HAMMER_LAB ss1795244562 Sep 08, 2015 (146)
72 WEILL_CORNELL_DGM ss1919031046 Feb 12, 2016 (147)
73 ILLUMINA ss1958330594 Feb 12, 2016 (147)
74 GENOMED ss1966894266 Jul 19, 2016 (147)
75 JJLAB ss2020031327 Sep 14, 2016 (149)
76 ILLUMINA ss2094785025 Dec 20, 2016 (150)
77 ILLUMINA ss2094982019 Dec 20, 2016 (150)
78 USC_VALOUEV ss2148058720 Dec 20, 2016 (150)
79 HUMAN_LONGEVITY ss2167388222 Dec 20, 2016 (150)
80 SYSTEMSBIOZJU ss2624524921 Nov 08, 2017 (151)
81 ILLUMINA ss2632590763 Nov 08, 2017 (151)
82 ILLUMINA ss2632590764 Nov 08, 2017 (151)
83 ILLUMINA ss2632590765 Nov 08, 2017 (151)
84 GRF ss2698036876 Nov 08, 2017 (151)
85 GNOMAD ss2732042355 Nov 08, 2017 (151)
86 GNOMAD ss2746493956 Nov 08, 2017 (151)
87 GNOMAD ss2762504184 Nov 08, 2017 (151)
88 AFFY ss2984884728 Nov 08, 2017 (151)
89 AFFY ss2985529897 Nov 08, 2017 (151)
90 SWEGEN ss2987924052 Nov 08, 2017 (151)
91 ILLUMINA ss3021149801 Nov 08, 2017 (151)
92 CSHL ss3343761112 Nov 08, 2017 (151)
93 ILLUMINA ss3625553663 Oct 11, 2018 (152)
94 ILLUMINA ss3626236235 Oct 11, 2018 (152)
95 ILLUMINA ss3630622670 Oct 11, 2018 (152)
96 ILLUMINA ss3636036300 Oct 11, 2018 (152)
97 ILLUMINA ss3637794640 Oct 11, 2018 (152)
98 ILLUMINA ss3641622946 Oct 11, 2018 (152)
99 ILLUMINA ss3642803170 Oct 11, 2018 (152)
100 OMUKHERJEE_ADBS ss3646248642 Oct 11, 2018 (152)
101 ILLUMINA ss3651486543 Oct 11, 2018 (152)
102 ILLUMINA ss3651486544 Oct 11, 2018 (152)
103 ILLUMINA ss3653654022 Oct 11, 2018 (152)
104 EGCUT_WGS ss3655867197 Jul 12, 2019 (153)
105 EVA_DECODE ss3687989788 Jul 12, 2019 (153)
106 ILLUMINA ss3725077992 Jul 12, 2019 (153)
107 ACPOP ss3727579298 Jul 12, 2019 (153)
108 EVA ss3746938022 Jul 12, 2019 (153)
109 PAGE_CC ss3770850803 Jul 12, 2019 (153)
110 PACBIO ss3783597415 Jul 12, 2019 (153)
111 PACBIO ss3789224010 Jul 12, 2019 (153)
112 PACBIO ss3794096072 Jul 12, 2019 (153)
113 EVA ss3823683669 Apr 25, 2020 (154)
114 EVA ss3825580202 Apr 25, 2020 (154)
115 EVA ss3826480620 Apr 25, 2020 (154)
116 EVA ss3836636456 Apr 25, 2020 (154)
117 SGDP_PRJ ss3850224915 Apr 25, 2020 (154)
118 KRGDB ss3895460800 Apr 25, 2020 (154)
119 FSA-LAB ss3983953191 Apr 25, 2021 (155)
120 FSA-LAB ss3983953192 Apr 25, 2021 (155)
121 EVA ss3984466849 Apr 25, 2021 (155)
122 EVA ss3984832818 Apr 25, 2021 (155)
123 EVA ss3986013958 Apr 25, 2021 (155)
124 EVA ss3986146521 Apr 25, 2021 (155)
125 EVA ss4016944578 Apr 25, 2021 (155)
126 TOPMED ss4471980427 Apr 25, 2021 (155)
127 TOMMO_GENOMICS ss5146959541 Apr 25, 2021 (155)
128 EVA ss5237633408 Oct 12, 2022 (156)
129 1000G_HIGH_COVERAGE ss5244658671 Oct 12, 2022 (156)
130 EVA ss5314659755 Oct 12, 2022 (156)
131 EVA ss5322718682 Oct 12, 2022 (156)
132 HUGCELL_USP ss5445207742 Oct 12, 2022 (156)
133 EVA ss5512473836 Oct 12, 2022 (156)
134 1000G_HIGH_COVERAGE ss5518170280 Oct 12, 2022 (156)
135 EVA ss5623917242 Oct 12, 2022 (156)
136 EVA ss5623999742 Oct 12, 2022 (156)
137 SANFORD_IMAGENETICS ss5624221332 Oct 12, 2022 (156)
138 SANFORD_IMAGENETICS ss5626802100 Oct 12, 2022 (156)
139 EVA ss5800047216 Oct 12, 2022 (156)
140 EVA ss5800087238 Oct 12, 2022 (156)
141 EVA ss5832811813 Oct 12, 2022 (156)
142 EVA ss5847169028 Oct 12, 2022 (156)
143 EVA ss5847562184 Oct 12, 2022 (156)
144 EVA ss5848277537 Oct 12, 2022 (156)
145 EVA ss5910665153 Oct 12, 2022 (156)
146 EVA ss5936512939 Oct 12, 2022 (156)
147 EVA ss5938603862 Oct 12, 2022 (156)
148 EVA ss5979294376 Oct 12, 2022 (156)
149 EVA ss5979997095 Oct 12, 2022 (156)
150 EVA ss5981198647 Oct 12, 2022 (156)
151 1000Genomes_30x NC_000001.11 - 169549811 Oct 12, 2022 (156)
152 gnomAD - Genomes NC_000001.11 - 169549811 Apr 25, 2021 (155)
153 HapMap NC_000001.11 - 169549811 Apr 25, 2020 (154)
154 KOREAN population from KRGDB NC_000001.10 - 169519049 Apr 25, 2020 (154)
155 The PAGE Study NC_000001.11 - 169549811 Jul 12, 2019 (153)
156 TopMed NC_000001.11 - 169549811 Apr 25, 2021 (155)
157 ALFA NC_000001.11 - 169549811 Apr 25, 2021 (155)
158 ClinVar RCV000000675.6 Oct 12, 2022 (156)
159 ClinVar RCV000000676.5 Oct 12, 2022 (156)
160 ClinVar RCV000023935.5 Oct 12, 2022 (156)
161 ClinVar RCV000205002.18 Oct 12, 2022 (156)
162 ClinVar RCV000454249.9 Oct 12, 2022 (156)
163 ClinVar RCV000514863.17 Oct 12, 2022 (156)
164 ClinVar RCV000616414.4 Oct 12, 2022 (156)
165 ClinVar RCV001081351.5 Oct 12, 2022 (156)
166 ClinVar RCV001095681.2 Oct 12, 2022 (156)
167 ClinVar RCV001806997.2 Oct 12, 2022 (156)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs1801711 Jan 04, 2002 (102)
rs60031897 May 25, 2008 (130)
Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
2638194, ss3895460800 NC_000001.10:169519048:T:A NC_000001.11:169549810:C:A (self)
ss77657762, ss80768688, ss84523906 NC_000001.8:166250706:T:T NC_000001.11:169549810:C:T (self)
ss87863257, ss108686946, ss111314932, ss119081774, ss164374094, ss165406825, ss167258185, ss199221578, ss205068124, ss253592200, ss276094736, ss284172225, ss290659975, ss482137838, ss491609172, ss1397263621, ss1585179911, ss1712380140, ss3642803170 NC_000001.9:167785672:T:T NC_000001.11:169549810:C:T (self)
2638194, ss218708130, ss230774116, ss238413632, ss342010061, ss482205031, ss483027973, ss489776588, ss491305652, ss535048159, ss554827710, ss648487054, ss780124263, ss781957563, ss835607295, ss974438194, ss975794409, ss1067428640, ss1068350648, ss1293348588, ss1426011906, ss1574463850, ss1584012785, ss1601439505, ss1644433538, ss1685903694, ss1710931971, ss1795244562, ss1919031046, ss1958330594, ss1966894266, ss2020031327, ss2094785025, ss2094982019, ss2148058720, ss2624524921, ss2632590763, ss2632590764, ss2632590765, ss2698036876, ss2732042355, ss2746493956, ss2762504184, ss2984884728, ss2985529897, ss2987924052, ss3021149801, ss3343761112, ss3625553663, ss3626236235, ss3630622670, ss3636036300, ss3637794640, ss3641622946, ss3646248642, ss3651486543, ss3651486544, ss3653654022, ss3655867197, ss3727579298, ss3746938022, ss3783597415, ss3789224010, ss3794096072, ss3823683669, ss3825580202, ss3826480620, ss3836636456, ss3850224915, ss3895460800, ss3983953191, ss3983953192, ss3984466849, ss3984832818, ss3986013958, ss3986146521, ss4016944578, ss5146959541, ss5314659755, ss5322718682, ss5512473836, ss5623917242, ss5623999742, ss5624221332, ss5626802100, ss5800047216, ss5800087238, ss5832811813, ss5847169028, ss5847562184, ss5848277537, ss5936512939, ss5938603862, ss5979294376, ss5979997095, ss5981198647 NC_000001.10:169519048:T:T NC_000001.11:169549810:C:T (self)
RCV000000675.6, RCV000000676.5, RCV000023935.5, RCV000205002.18, RCV000454249.9, RCV000616414.4, RCV001095681.2, RCV001806997.2, 5696215, 30071582, 199789, 72272, 35586762, 1793490053, ss169613390, ss252841304, ss2167388222, ss3687989788, ss3725077992, ss3770850803, ss4471980427, ss5237633408, ss5244658671, ss5445207742, ss5518170280, ss5910665153 NC_000001.11:169549810:C:T NC_000001.11:169549810:C:T (self)
ss7639, ss3388517, ss6408627, ss12674255, ss68784225, ss74903136, ss97982940, ss105435572, ss106609833, ss131709017, ss138101430, ss155905226, ss159699610, ss160758444, ss173964819, ss181341854, ss244304161 NT_004487.19:21007690:T:T NC_000001.11:169549810:C:T (self)
ss14458528, ss15384064, ss17374119, ss20553759 NT_004668.16:8024520:T:T NC_000001.11:169549810:C:T (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

184 citations for rs6025
PMID Title Author Year Journal
7586244 Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Ridker PM et al. 1995 Circulation
7803250 High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis. Beauchamp NJ et al. 1994 British journal of haematology
7877648 Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. Ridker PM et al. 1995 The New England journal of medicine
7910348 Activated protein C resistance caused by Arg506Gln mutation in factor Va. Greengard JS et al. 1994 Lancet (London, England)
7911872 Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. Voorberg J et al. 1994 Lancet (London, England)
7968118 Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Vandenbroucke JP et al. 1994 Lancet (London, England)
8049422 Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Koeleman BP et al. 1994 Blood
8164730 Human genetics. Bad blood by mutation. Majerus PW et al. 1994 Nature
8164741 Mutation in blood coagulation factor V associated with resistance to activated protein C. Bertina RM et al. 1994 Nature
8566967 Population study of the G1691A mutation (R506Q, FV Leiden) in the human factor V gene that is associated with resistance to activated protein C. Braun A et al. 1996 Human genetics
8616100 HELLP syndrome associated with factor V R506Q mutation. Brenner B et al. 1996 British journal of haematology
8822583 Inherited prethrombotic disorders and infectious purpura. Westendorp RG et al. 1996 Thrombosis and haemostasis
9245936 Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Mahmoud AE et al. 1997 Gut
9339109 The prevalence of factor V Leiden (1691 G-->A) mutation in Turkey. Gürgey A et al. 1997 The Turkish journal of pediatrics
9372726 Retinal arterial occlusion in a child with factor V Leiden and thermolabile methylene tetrahydrofolate reductase mutations. Talmon T et al. 1997 American journal of ophthalmology
9415695 Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations. Gregg JP et al. 1997 American journal of medical genetics
9454741 A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Chan WP et al. 1998 Blood
9459326 Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss--a possible evolutionary selection mechanism. Lindqvist PG et al. 1998 Thrombosis and haemostasis
9518910 Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group. de Bruijn SF et al. 1998 BMJ (Clinical research ed.)
9734642 Budd-Chiari syndrome, portal vein and mesenteric vein thrombosis in a patient homozygous for factor V Leiden mutation treated by TIPS and thrombolysis. Leebeek FW et al. 1998 British journal of haematology
10328130 Homozygous factor V Leiden mutation in a child with Budd-Chiari syndrome. Gürakan F et al. 1999 Journal of pediatric gastroenterology and nutrition
10348711 Simultaneous genotyping for factor V Leiden and prothrombin G20210A variant by a multiplex PCR-SSCP assay on whole blood. Meyer M et al. 1999 Thrombosis and haemostasis
10477778 The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. De Stefano V et al. 1999 The New England journal of medicine
10494770 Familial coagulation factor V deficiency caused by a novel 4 base pair insertion in the factor V gene: factor V Stanford. Zehnder JL et al. 1999 Thrombosis and haemostasis
10507841 Double-homozygosity for factor V Leiden and the prothrombin gene G20210A variant in a young patient with idiopathic venous thrombosis. Mainardi JR et al. 1999 Blood
10666427 Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. Gerhardt A et al. 2000 The New England journal of medicine
11018168 Mutations in coagulation factors in women with unexplained late fetal loss. Martinelli I et al. 2000 The New England journal of medicine
11583312 Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Emmerich J et al. 2001 Thrombosis and haemostasis
11686338 Improved hemoglobin status and reduced menstrual blood loss among female carriers of factor V Leiden--an evolutionary advantage? Lindqvist PG et al. 2001 Thrombosis and haemostasis
12069454 Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use. Legnani C et al. 2002 European heart journal
14996674 Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Juul K et al. 2004 Annals of internal medicine
15208046 Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives. Sidney S et al. 2004 Contraception
15534175 Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Casas JP et al. 2004 Archives of neurology
15638861 R255h amino acid substitution of protein Z identified in patients with factor V Leiden mutation. Kemkes-Matthes B et al. 2005 British journal of haematology
15946211 Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke. Slooter AJ et al. 2005 Journal of thrombosis and haemostasis
16493002 Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24,000 years ago. Zivelin A et al. 2006 Blood
16769590 Oral contraceptive use, thrombophilia and their interaction in young women with ischemic stroke. Martinelli I et al. 2006 Haematologica
16846490 Lemierre's syndrome and genetic polymorphisms: a case report. Constantin JM et al. 2006 BMC infectious diseases
17048007 Association of warfarin dose with genes involved in its action and metabolism. Wadelius M et al. 2007 Human genetics
17107626 Comparison of PrASE and Pyrosequencing for SNP Genotyping. Käller M et al. 2006 BMC genomics
17677000 Combined effects of thrombosis pathway gene variants predict cardiovascular events. Auro K et al. 2007 PLoS genetics
18513389 New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background. Penco S et al. 2008 BMC bioinformatics
18752569 Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: a genetic association study and meta-analysis. Dudding T et al. 2008 Journal of thrombosis and haemostasis
18805967 Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping. Johnson DC et al. 2008 Blood
18936436 Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. Chang MH et al. 2009 American journal of epidemiology
19131662 A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Wang X et al. 2009 Stroke
19263529 Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach. Zee RY et al. 2009 Clinica chimica acta; international journal of clinical chemistry
19330901 Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the Women's Genome Health Study. Conen D et al. 2009 Journal of hypertension
19415820 The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13 ) on the effectiveness of statins: the GenHAT study. Maitland-van der Zee AH et al. 2009 Pharmacogenetics and genomics
19536175 Follow-up of a major linkage peak on chromosome 1 reveals suggestive QTLs associated with essential hypertension: GenNet study. Ehret GB et al. 2009 European journal of human genetics
19538716 Thrombotic genetic risk factors and warfarin pharmacogenetic variants in São Miguel's healthy population (Azores). Branco CC et al. 2009 Thrombosis journal
19559392 A candidate gene association study of 77 polymorphisms in migraine. Schürks M et al. 2009 The journal of pain
19591822 Prevalence of genetic thrombophilic polymorphisms in the Sri Lankan population--implications for association study design and clinical genetic testing services. Dissanayake VH et al. 2009 Experimental and molecular pathology
19682239 Replication of findings on the association of genetic variation in 24 hemostasis genes and risk of incident venous thrombosis. Smith NL et al. 2009 Journal of thrombosis and haemostasis
19786296 Platelet glycoprotein GP VI 13254C allele is an independent risk factor of premature myocardial infarction. Motovska Z et al. 2010 Thrombosis research
20031567 An evaluation of candidate genes of inflammation and thrombosis in relation to the risk of venous thromboembolism: The Women's Genome Health Study. Zee RY et al. 2009 Circulation. Cardiovascular genetics
20352152 Association of common genetic variations and idiopathic venous thromboembolism. Results from EDITh, a hospital-based case-control study. Delluc A et al. 2010 Thrombosis and haemostasis
20417488 Association of fetal inflammation and coagulation pathway gene polymorphisms with neurodevelopmental delay at age 2 years. Clark EA et al. 2010 American journal of obstetrics and gynecology
20556870 CLIA-tested genetic variants on commercial SNP arrays: potential for incidental findings in genome-wide association studies. Johnson AD et al. 2010 Genetics in medicine
21054877 Inflammation gene variants and susceptibility to albuminuria in the U.S. population: analysis in the Third National Health and Nutrition Examination Survey (NHANES III), 1991-1994. Ned RM et al. 2010 BMC medical genetics
21116184 Factor V Leiden thrombophilia. Kujovich JL et al. 2011 Genetics in medicine
21121051 The reference human genome demonstrates high risk of type 1 diabetes and other disorders. Chen R et al. 2011 Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
21163921 Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis. Smith NL et al. 2011 Blood
21291465 The association of genetic polymorphisms with cerebral palsy: a meta-analysis. Wu D et al. 2011 Developmental medicine and child neurology
21332313 Sequence variations in the FII, FV, F13A1, FGB and PAI-1 genes are associated with differences in myocardial perfusion. Satra M et al. 2011 Pharmacogenomics
21422408 Clotting factor gene polymorphisms and colorectal cancer risk. Vossen CY et al. 2011 Journal of clinical oncology
21463476 Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism. Heit JA et al. 2011 Journal of thrombosis and haemostasis
21502573 Genetic predictors of fibrin D-dimer levels in healthy adults. Smith NL et al. 2011 Circulation
21564075 Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism. Bergrem A et al. 2011 British journal of haematology
21659962 Replication of genetic associations in the inflammation, complement, and coagulation pathways with intraventricular hemorrhage in LBW preterm neonates. Ryckman KK et al. 2011 Pediatric research
21857382 Candidate genes and risk for CP: a population-based study. Wu YW et al. 2011 Pediatric research
21894447 Are centenarians genetically predisposed to lower disease risk? Ruiz JR et al. 2012 Age (Dordrecht, Netherlands)
21919968 Validation of genetic variants associated with early acute rejection in kidney allograft transplantation. Oetting WS et al. 2012 Clinical transplantation
21935354 Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. Dewey FE et al. 2011 PLoS genetics
21955043 Validation of single nucleotide polymorphisms associated with acute rejection in kidney transplant recipients using a large multi-center cohort. Oetting WS et al. 2011 Transplant international
22273812 Replication and characterisation of genetic variants in the fibrinogen gene cluster with plasma fibrinogen levels and haematological traits in the Third National Health and Nutrition Examination Survey. Jeff JM et al. 2012 Thrombosis and haemostasis
22295056 Genome wide association identifies PPFIA1 as a candidate gene for acute lung injury risk following major trauma. Christie JD et al. 2012 PloS one
22353194 Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes. Lotta LA et al. 2012 BMC medical genomics
22388798 Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study. Lynch AI et al. 2012 Pharmacogenetics and genomics
22403240 Associations between incident ischemic stroke events and stroke and cardiovascular disease-related genome-wide association studies single nucleotide polymorphisms in the Population Architecture Using Genomics and Epidemiology study. Carty CL et al. 2012 Circulation. Cardiovascular genetics
22421107 The G534E-polymorphism of the gene encoding the factor VII-activating protease is a risk factor for venous thrombosis and recurrent events. Ahmad-Nejad P et al. 2012 Thrombosis research
22540831 Candidate gene study of genetic thrombophilic polymorphisms in pre-eclampsia and recurrent pregnancy loss in Sinhalese women. Dissanayake VH et al. 2012 The journal of obstetrics and gynaecology research
22707612 Genetic risk factors for thrombosis in systemic lupus erythematosus. Kaiser R et al. 2012 The Journal of rheumatology
22879966 Systematic testing of literature reported genetic variation associated with coronary restenosis: results of the GENDER Study. Verschuren JJ et al. 2012 PloS one
22992668 Pharmacogenomics knowledge for personalized medicine. Whirl-Carrillo M et al. 2012 Clinical pharmacology and therapeutics
23016735 Personalized approach of medication by indirect anticoagulants tailored to the patient-Russian context: what are the prospects? Belozerceva LA et al. 2012 The EPMA journal
23018527 Necessity and risks of arterial blood sampling in healthy volunteer studies. Oertel BG et al. 2012 Clinical pharmacokinetics
23132613 Genetic association studies in pre-eclampsia: systematic meta-analyses and field synopsis. Staines-Urias E et al. 2012 International journal of epidemiology
23150947 Single nucleotide polymorphisms and the risk of venous thrombosis: results from a Danish case-cohort study. El-Galaly TC et al. 2013 British journal of haematology
23274712 Genetic polymorphisms and the risk of myocardial infarction in patients under 45 years of age. Sakowicz A et al. 2013 Biochemical genetics
23533563 Novel risk factors for premature peripheral arterial occlusive disease in non-diabetic patients: a case-control study. Bérard AM et al. 2013 PloS one
23650146 A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Tang W et al. 2013 Genetic epidemiology
23776350 Gene polymorphisms in association with self-reported stroke in US adults. Fan AZ et al. 2010 The application of clinical genetics
23820649 Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Cooper DN et al. 2013 Human genetics
23900608 Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Simone B et al. 2013 European journal of epidemiology
24270849 Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Denny JC et al. 2013 Nature biotechnology
24485400 Influence of factor 5 rs6025 and factor 2 rs1799963 mutation on inhibitor development in patients with hemophilia A--an Israeli-German multicenter database study. Kenet G et al. 2014 Thrombosis research
24816905 Single nucleotide variants in the protein C pathway and mortality in dialysis patients. Ocak G et al. 2014 PloS one
24908450 A genetic association study of D-dimer levels with 50K SNPs from a candidate gene chip in four ethnic groups. Weng LC et al. 2014 Thrombosis research
25266489 Genetic polymorphisms of VIP variants in the Tajik ethnic group of northwest China. Zhang J et al. 2014 BMC genetics
25272994 Role of protein S deficiency in children with venous thromboembolism. An observational international cohort study. Klostermeier UC et al. 2015 Thrombosis and haemostasis
25333069 Disease variants in genomes of 44 centenarians. Freudenberg-Hua Y et al. 2014 Molecular genetics & genomic medicine
25341889 Multilocus genetic risk scores for venous thromboembolism risk assessment. Soria JM et al. 2014 Journal of the American Heart Association
25361584 Subgroups at high risk for ischaemic heart disease:identification and validation in 67 000 individuals from the general population. Frikke-Schmidt R et al. 2015 International journal of epidemiology
25474356 Highly significant association between two common single nucleotide polymorphisms in CORIN gene and preeclampsia in Caucasian women. Stepanian A et al. 2014 PloS one
25741868 Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Richards S et al. 2015 Genetics in medicine
25897999 Tobacco smoking strongly modifies the association of prothrombin G20210A with undetermined stroke: consecutive survivors and population-based controls. Krajcoviechova A et al. 2015 Atherosclerosis
25937265 Protective effect of compression socks in a marathon runner with a genetic predisposition to thrombophilia due to Factor V Leiden. Zaleski AL et al. 2015 The Physician and sportsmedicine
26091847 Genetic polymorphisms of pharmacogenomic VIP variants in the Uygur population from northwestern China. Wang L et al. 2015 BMC genetics
26261166 A preliminary study of inherited thrombophilic risk factors in different clinical manifestations of venous thromboembolism in central Iran. Karimi A et al. 2015 The Indian journal of medical research
26423325 F11 is associated with recurrent VTE in women. A prospective cohort study. Bruzelius M et al. 2016 Thrombosis and haemostasis
26592644 Detection of human genome mutations associated with pregnancy complications using 3-D microarray based on macroporous polymer monoliths. Glotov AS et al. 2016 Talanta
26747084 Genetic studies of Polish migraine patients: screening for causative mutations in four migraine-associated genes. Domitrz I et al. 2016 Human genomics
26791477 The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study. Do AN et al. 2016 Journal of human hypertension
26856649 Nutritional habits, lifestyle, and genetic predisposition in cardiovascular and metabolic traits in Turkish population. Karaca S et al. 2016 Nutrition (Burbank, Los Angeles County, Calif.)
26888256 Novel genetic predictors of venous thromboembolism risk in African Americans. Hernandez W et al. 2016 Blood
26970916 Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study. Perez Botero J et al. 2016 European journal of internal medicine
26982741 Single Nucleotide Variant rs2232710 in the Protein Z-Dependent Protease Inhibitor (ZPI, SERPINA10) Gene Is Not Associated with Deep Vein Thrombosis. Gorski MM et al. 2016 PloS one
27018927 Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort. Aydin H et al. 2016 Ophthalmic genetics
27156530 Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utility. Ye BD et al. 2016 Expert review of clinical immunology
27233255 Association of gene polymorphisms of FV, FII, MTHFR, SERPINE1, CTLA4, IL10, and TNFalpha with pre-eclampsia in Chinese women. Zhou L et al. 2016 Inflammation research
27233804 Genetic polymorphisms of pharmacogenomic VIP variants in the Mongol of Northwestern China. Jin T et al. 2016 BMC genetics
27277665 Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population. Zholdybayeva EV et al. 2016 Human genomics
27348238 Association Between Gene Polymorphisms on Chromosome 1 and Susceptibility to Pre-Eclampsia: An Updated Meta-Analysis. Zhang G et al. 2016 Medical science monitor
27384325 Exome sequencing in pooled DNA samples to identify maternal pre-eclampsia risk variants. Kaartokallio T et al. 2016 Scientific reports
27589735 A Genomics-Based Model for Prediction of Severe Bioprosthetic Mitral Valve Calcification. Ponasenko AV et al. 2016 International journal of molecular sciences
27616475 Gene variants as risk factors for gastroschisis. Padula AM et al. 2016 American journal of medical genetics. Part A
27636225 An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision Medicine. Mnika K et al. 2016 Omics
27716216 The Anatomy to Genomics (ATG) Start Genetics medical school initiative: incorporating exome sequencing data from cadavers used for Anatomy instruction into the first year curriculum. Gerhard GS et al. 2016 BMC medical genomics
27766050 Causes of venous thrombosis. Rosendaal FR et al. 2016 Thrombosis journal
27976734 The Unravelling of the Genetic Architecture of Plasminogen Deficiency and its Relation to Thrombotic Disease. Martin-Fernandez L et al. 2016 Scientific reports
28086795 Atherosclerotic and thrombotic genetic and environmental determinants in Egyptian coronary artery disease patients: a pilot study. Fawzy MS et al. 2017 BMC cardiovascular disorders
28317214 Characterization of blood flow through intrapulmonary arteriovenous anastomoses and patent foramen ovale at rest and during exercise in stroke and transient ischemic attack patients. Romac R et al. 2017 Echocardiography (Mount Kisco, N.Y.)
28345611 Copy number variation profile in the placental and parental genomes of recurrent pregnancy loss families. Kasak L et al. 2017 Scientific reports
28544373 Genetic markers for inherited thrombophilia are associated with fetal growth retardation in the population of Central Russia. Reshetnikov E et al. 2017 The journal of obstetrics and gynaecology research
28889200 Prevalence of common hereditary risk factors for thrombophilia in Somalia and identification of a novel Gln544Arg mutation in coagulation factor V. Abdi AA et al. 2017 Journal of thrombosis and thrombolysis
29094466 Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study. Horvei LD et al. 2018 Journal of thrombosis and haemostasis
29190926 Polymorphism of the ABO gene associate with thrombosis risk in patients with paroxysmal nocturnal hemoglobinuria. Long Z et al. 2017 Oncotarget
29334895 Challenges imposed by minor reference alleles on the identification and reporting of clinical variants from exome data. Koko M et al. 2018 BMC genomics
29518638 Thrombophilia testing in children: What and when should be tested? Nowak-Göttl U et al. 2018 Thrombosis research
29624150 Frequency and characteristics associated with inherited thrombophilia in patients with intracranial dural arteriovenous fistula. LaHue SC et al. 2019 Journal of neurosurgery
30182779 Genetic susceptibility to cerebrovascular disease: A systematic review. Griessenauer CJ et al. 2018 Journal of cerebral blood flow and metabolism
30727925 Relationship Between Single-Nucleotide Polymorphisms of Tumor Necrosis Factor Alpha, Interleukin-10, Factor II and Factor V with Risk of Inhibitor Development in Patients with Severe Hemophilia A. Soori S et al. 2019 Cardiovascular & hematological disorders drug targets
30773804 Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The Tromsø Study. Rinde LB et al. 2019 Journal of thrombosis and haemostasis
30842582 Minor allele of the factor V K858R variant protects from venous thrombosis only in non-carriers of factor V Leiden mutation. Ibrahim-Kosta M et al. 2019 Scientific reports
30858532 Whole-Exome Sequencing in the Isolated Populations of Cilento from South Italy. Nutile T et al. 2019 Scientific reports
31019283 Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests. Thauvin-Robinet C et al. 2019 European journal of human genetics
31037802 Association of hypertensive disorders of pregnancy risk and factor V Leiden mutation: A meta-analysis. Li Y et al. 2019 The journal of obstetrics and gynaecology research
31058051 Recurrent Miscarriage and Implantation Failure of Unknown Cause Studied by a Panel of Thrombophilia Conditions: Increased Frequency of FXIII Val34Leu Polymorphism. Diaz-Nuñez M et al. 2019 Journal of reproduction & infertility
31101755 Increased incidence of cancer in the follow-up of obstetric antiphospholipid syndrome within the NOH-APS cohort. Gris JC et al. 2020 Haematologica
31124268 Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism. Småbrekke B et al. 2019 Journal of thrombosis and haemostasis
31134135 Pleiotropic Meta-Analysis of Age-Related Phenotypes Addressing Evolutionary Uncertainty in Their Molecular Mechanisms. Kulminski AM et al. 2019 Frontiers in genetics
31420334 Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism. Lindström S et al. 2019 Blood
31615384 [Hemostatic Gene Polymorphisms in Acute Coronary Syndrome with Nonobstructive Coronary Atherosclerosis]. Fedorova SB et al. 2019 Kardiologiia
31646966 MTHFR and F5 genetic variations have association with preeclampsia in Pakistani patients: a case control study. Khidri FF et al. 2019 BMC medical genetics
31689458 Venous thromboembolism GWAS reported genetic makeup and the hallmarks of cancer: Linkage to ovarian tumour behaviour. Tavares V et al. 2020 Biochimica et biophysica acta. Reviews on cancer
32110755 Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study. Sejrup JK et al. 2020 Research and practice in thrombosis and haemostasis
32342502 The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk. Khialani D et al. 2020 British journal of haematology
32402998 Prothrombotic genotypes and risk of major bleeding in patients with incident venous thromboembolism. Johnsen HS et al. 2020 Thrombosis research
32496628 Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker-Induced Angioedema. Maroteau C et al. 2020 Clinical pharmacology and therapeutics
32594420 Role of prothrombin 19911 A>G polymorphism, blood group and male gender in patients with venous thromboembolism: Results of a German cohort study. Limperger V et al. 2021 Journal of thrombosis and thrombolysis
32671915 Combined effects of five prothrombotic genotypes and cancer on the risk of a first venous thromboembolic event. Skille H et al. 2020 Journal of thrombosis and haemostasis
32695137 Workflow for the Implementation of Precision Genomics in Healthcare. Mehandziska S et al. 2020 Frontiers in genetics
32731838 Genetic risk factors for venous thromboembolism. Zöller B et al. 2020 Expert review of hematology
32952508 Association of Four Missense SNPs with Preeclampsia in Saudi Women. Aljuaid NM et al. 2020 Saudi journal of medicine & medical sciences
33128086 Genetic association study of fatal pulmonary embolism. Meißner L et al. 2021 International journal of legal medicine
33170161 Genetic test for the prescription of diets in support of physical activity. Naureen Z et al. 2020 Acta bio-medica
33448877 Prevalence of the Factor V Leiden Mutation Arg534Gln in Western Region of Saudi Arabia: Functional Alteration and Association Study With Different Populations. Athar M et al. 2021 Clinical and applied thrombosis/hemostasis
33519226 Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon. Fernandes MR et al. 2021 Pharmacogenomics and personalized medicine
33940655 Joint Effect of Multiple Prothrombotic Genotypes and Obesity on the Risk of Incident Venous Thromboembolism. Frischmuth T et al. 2022 Thrombosis and haemostasis
34087973 Bosnian Study on Markers of Ischaemic Stroke in Adults 20-50 Years Old (SMISAO): Preliminary Report. Mahmutbegovic N et al. 2020 Folia biologica
34142473 Correlation between the Polymorphism of Coagulation-Related Genes and Lower Extremity Deep Venous Thrombosis. Jiang YR et al. 2021 Fa yi xue za zhi
34200207 Genetic Risk Profiling Associated with Recurrent Unprovoked Venous Thromboembolism. Hodeib H et al. 2021 Genes
34207366 Cis-Segregation of c.1171C>T Stop Codon (p.R391*) in SERPINC1 Gene and c.1691G>A Transition (p.R506Q) in F5 Gene and Selected GWAS Multilocus Approach in Inherited Thrombophilia. Gemmati D et al. 2021 Genes
34234248 An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism. Razzaq M et al. 2021 Scientific reports
34263111 Predictive Ability of a Clinical-Genetic Risk Score for Venous Thromboembolism in Northern and Southern European Populations. Salas E et al. 2021 TH open
34356593 PlA2 Polymorphism of Platelet Glycoprotein IIb/IIIa and C677T Polymorphism of Methylenetetrahydrofolate Reductase (MTHFR), but Not Factor V Leiden and Prothrombin G20210A Polymorphisms, Are Associated with More Severe Forms of Legg-Calvé-Perthes Disease. García-Alfaro MD et al. 2021 Children (Basel, Switzerland)
34765649 The Higher Prevalence of Venous Thromboembolism in the Hungarian Roma Population Could Be Due to Elevated Genetic Risk and Stronger Gene-Environmental Interactions. Natae SF et al. 2021 Frontiers in cardiovascular medicine
34784644 The Risk of Venous Thromboembolism Attributed to Established Prothrombotic Genotypes. Evensen LH et al. 2022 Thrombosis and haemostasis
34958284 Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes. Muyambo S et al. 2022 Omics
34970867 Thrombomodulin (THBD) gene variants and thrombotic risk in a population-based cohort study. Manderstedt E et al. 2022 Journal of thrombosis and haemostasis
35316569 Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001. Athale UH et al. 2022 Pediatric blood & cancer
35346283 Integrative analyses of genes related to femoral head osteonecrosis: an umbrella review of systematic reviews and meta-analyses of observational studies. Lee S et al. 2022 Journal of orthopaedic surgery and research
35453794 SERPINE1 rs6092 Variant Is Related to Plasma Coagulation Proteins in Patients with Severe COVID-19 from a Tertiary Care Hospital. Fricke-Galindo I et al. 2022 Biology
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post825+45319f0